Trump announces all 50 states joining Medicaid drug pricing model
The White House said the model will save Medicaid $64.3 billion over 10 years as drugmakers agree to supplemental rebates on hundreds of medicines.
- On Friday, President Donald Trump announced the expansion of the "Most Favored Nation" drug pricing model to all 50 states, the District of Columbia, and Puerto Rico, aligning U.S. prescription costs with international rates.
- Dubbed the Medicaid "GENEROUS" model, the initiative relies on agreements with global manufacturers including Pfizer, Eli Lilly, and Novo Nordisk to secure lower prices comparable to other developed nations.
- The White House Council of Economic Advisers projects the effort could save $529 billion over 10 years, including $27.6 billion in net savings for state governments and $36.6 billion in federal savings.
- Kathy Hempstead, a senior policy advisor at the Robert Wood Johnson Foundation, warned that the lack of public deal details creates a barrier to legislative action and pressures the administration to release granular data.
112 Articles
112 Articles
Trump announced that all states will participate in a program to bring the price of medicines back to the level of other countries.
Trump Announces Most Favored Nation Drug Pricing Will Now Be Available Under Medicaid in All 50 States * The Gateway Pundit * by Jordan Conradson
President Trump on Friday announced in the Oval Office that all 50 states have signed on to his agreements on most-favored-nation pricing on prescription drugs under Medicaid. "This will save states billions and billions of dollars per year on drugs and allow them to invest those savings in providing better health care and higher quality service for the American people," Trump told reporters.
Trump, Tate Reeves announce lower Medicaid drug prices
Mississippi Gov. Tate Reeves joined President Donald Trump at the White House on Friday as the administration announced a new plan aimed at lowering prescription drug costs for Medicaid programs nationwide.
Trump: Most-Favored-Nation Drug Pricing Extended to State Medicaid Programs
President Donald Trump announced Friday that the most-favored-nation (MFN) prices on prescription drugs in deals he struck with pharmaceutical companies are officially being extended to Medicaid programs in all 50 states, Washington, DC, and Puerto Rico.
All 50 states opt into Trump’s ‘favored nations’ drug pricing for Medicaid
President Trump announced Friday that all 50 states along with Puerto Rico and DC have opted into his “most favored nations’’ drug-price initiative to lower prescription costs for Medicaid recipients.
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
